A newly commissioned study conducted by Milliman in the traditional Medicare population found that nearly 70% of anxiety and insomnia patients are treated with prescription drugs only, and less than 10% receive the psychotherapy, which is indicated as first-line care. This webinar will discuss the study findings and offer perspectives on moving beyond medication to address critical gaps in behavioral health care.
Bringing together perspectives from psychology, psychiatry and health economics, this webinar will examine current treatment patterns among traditional Medicare beneficiaries, gaps in current reimbursement policies and the potential of digital treatments.
Submit the form to watch the replay
Here’s our latest
Case Study: Future of Mental Health Care: Challenges, Innovation & Employee Impact
The EBN Workplace Strategies Agenda Conference gathered senior leaders and industry experts to address the most critical issues facing the…
Innovations in Personalized Health
The National Alliance of Healthcare Purchaser Coalitions (National Alliance) is the only nonprofit, purchaser-led organization with a national and regional…
Both Sides of the Coin: Communicating the Impact of Mental Health Equity & ROI
With nearly half of adult Americans experiencing a clinical mental health issue over the past year, it’s clear we need…
